Assessment of the value of PEF (cisplatin, epirubicin, 5 fluorouracil) in advanced extrahepatic biliary tract and pancreatic cancer;Ocena wartości chemioterapii paliatywnej PEF (cisplatyna, epirubicyna, 5-fluorouracyl) w zaawansowanych rakach zewnatrzwatrobowych dróg zółciowych i trzustki.

Przegla̧d lekarski

Volumn 65, Issue 12, 2008, Pages 825-828

  Zygulska, Aneta L ^a   Pawlega, Janusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; EPIRUBICIN; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; FEMALE; HEPATIC DUCT; HUMAN; MALE; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PANCREAS TUMOR; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 67449107606     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)